Drug-Related Problems in Elderly Patients Attended to by Emergency Services DOI Open Access
Jesús Ruiz Ramos,

Adrián Plaza‐Díaz,

Cristina Roure-i-Nuez

et al.

Journal of Clinical Medicine, Journal Year: 2023, Volume and Issue: 13(1), P. 3 - 3

Published: Dec. 19, 2023

The progressive aging and comorbidities of the population have led to an increase in number patients with polypharmacy attended emergency department. Drug-related problems (DRPs) become a major cause admission these units, as well high rate short-term readmissions. Anticoagulants, antibiotics, antidiabetics, opioids been shown be most common drugs involved this issue. Inappropriate has pointed out one causes visits. Different ways conducting chronic medication reviews at discharge, primary care coordination, phone contact discharge reduce new hospitalizations room visits due DRPs, they are key elements for improving quality provided by services.

Language: Английский

Pharmacotherapy for overactive bladder syndrome and the risk of incident dementia DOI
David Sheyn, Jennifer Murphy, Abhimanyu Mahajan

et al.

World Journal of Urology, Journal Year: 2025, Volume and Issue: 43(1)

Published: April 4, 2025

Language: Английский

Citations

0

Comparison of Anticholinergic Burden Scales and Their Association with Cognitive and Functional Impairment in Older Adults: A Cross-Sectional Study Using the REPOSI Database DOI
Alessio Novella, Marina Azab, Luca Pasina

et al.

Drugs & Aging, Journal Year: 2025, Volume and Issue: unknown

Published: April 15, 2025

Language: Английский

Citations

0

Proceedings of the Canadian Medication Appropriateness and Deprescribing Network’s 2023 National Meeting DOI Creative Commons

Tiphaine Pierson,

Verna Arcand,

Barbara Farrell

et al.

Drug Safety, Journal Year: 2024, Volume and Issue: 47(9), P. 829 - 839

Published: June 17, 2024

In 2022, the network refreshed its purpose to encompass larger scope of safe and appropriate use medications for Canadians all ages hence was renamed Canadian Medication Appropriateness Deprescribing Network (CADeN).In 2023, CADeN, with expanded scope, united key players once more build a structured, pan-Canadian movement promote medication appropriateness people ages.This event funded by, held in partnership with, Health Canada. Attendance Goals National Meeting AttendanceThe CADeN 2023 on 8 9 November Montreal, QC, Canada, hosting 101 attendees.Attendees included public members, community leaders, healthcare providers, organization leaders appropriateness, researchers, trainees, policy makers from 10 13 provinces territories, along international experts invited USA Australia.Among government representatives attending were members Drug Agency Transition Office (CDATO).The Government Canada launched CDATO spring 2021, work provinces, stakeholders vision, mandate, plan establish (CDA) that would improve pharmaceutical system coordination support related work.This supported by Budget 2019 investment $35 million CAD over 4 years [20].As primary stakeholder CDATO, working partner Meeting.Members encouraged host consultations attendees help guide development CDA strategy supporting prescribing Canada.The aimed incorporate principles equity, diversity, inclusion among scientific organizing committee, keynote speakers, presenters, representation early career as well voices lived experience.

Language: Английский

Citations

2

Cognitive impact of anticholinergic and sedative burden in people living with HIV DOI
Henry Ukachukwu Michael, Marie‐Josée Brouillette, Robyn Tamblyn

et al.

AIDS, Journal Year: 2024, Volume and Issue: 38(13), P. 1819 - 1828

Published: June 20, 2024

This study aims to estimate the extent which anticholinergic and sedative burden is associated with cognitive ability self-reported difficulties (SCD) in middle-aged older adults living HIV.

Language: Английский

Citations

1

Prevalence of strong anticholinergic use in residents with and without cognitive impairment and frailty: analysis from 106 nursing homes in 12 Asia-Pacific and European countries DOI Creative Commons
Amanda J. Cross, Emanuele Rocco Villani, Agathe Daria Jadczak

et al.

Archives of Gerontology and Geriatrics, Journal Year: 2024, Volume and Issue: 128, P. 105636 - 105636

Published: Sept. 11, 2024

Language: Английский

Citations

1

The association between anticholinergic/sedative burden and physical frailty in people aging with HIV DOI Open Access
Henry Ukachukwu Michael, Marie‐Josée Brouillette, Robyn Tamblyn

et al.

AIDS, Journal Year: 2023, Volume and Issue: 38(4), P. 509 - 519

Published: Dec. 1, 2023

Objective: This study aimed to estimate the strength of association between anticholinergic/sedative burden and concurrent physical frailty in people aging with HIV. Design: cross-sectional analysis examined baseline data from 824 adults a mean age 53 enrolled Positive Brain Health Now study. Methods: Anticholinergic medications were identified using four methods: Cognitive Burden (ACB) Scale, Risk Scale (ARS), Drug (ADS), anticholinergic list Sedative Catalog (ACSBC). Sedatives Load Model (SLM) sedative ACSBC. Physical was assessed modified Fried Frailty Phenotype (FFP) based on self-report items. Multivariable logistic regression models, adjusted for sociodemographic factors, lifestyle considerations, HIV-related variables, comorbidities, co-medication use, used odds ratios (ORs). Results: demonstrated associations across various total (OR range: 1.22–1.32; 95% confidence interval (CI) 1.03–1.66), 1.18–1.24; CI 1.02–1.45), high 2.12–2.74; 1.03–6.19), 1.94–2.18; CI: 1.01–4.34). Conclusion: The burdens may represent modifiable risk factors Future studies should evaluate effects reducing outcomes explore prognostic value diverse scoring methods.

Language: Английский

Citations

2

Medication utilization patterns in patients with post-COVID syndrome (PCS): Implications for polypharmacy and drug–drug interactions DOI
Henry Ukachukwu Michael, Marie‐Josée Brouillette, Lesley K. Fellows

et al.

Journal of the American Pharmacists Association, Journal Year: 2024, Volume and Issue: 64(4), P. 102083 - 102083

Published: April 2, 2024

Language: Английский

Citations

0

Anticholinergic burden among in-patients: a cross-sectional study on prevalence, determinants, and impact on mortality in Ethiopia DOI Creative Commons
Eyob Alemayehu Gebreyohannes,

Wagaye Atalay Taye,

Biniam Siyum Shibe

et al.

Therapeutic Advances in Drug Safety, Journal Year: 2024, Volume and Issue: 15

Published: Jan. 1, 2024

Numerous studies report that anticholinergic burden (ACB) has been linked with several health consequences, including increased hospital admissions, prolonged hospitalization, and physical cognitive impairment. However, low- middle-income settings, as well younger individuals, are underrepresented.

Language: Английский

Citations

0

Anticholinergic and sedative medication use in persons with HIV: defining the evidence for risks on cognition DOI

Karl Goodkin,

Alan Winston,

Estebán Martínez

et al.

AIDS, Journal Year: 2024, Volume and Issue: 38(13), P. 1885 - 1887

Published: Sept. 26, 2024

Language: Английский

Citations

0

Systematic review on the use of anticholinergic scales in elderly chronic patients. DOI

Rocío Díaz-Acedo,

Ángela Villalba-Moreno, Bernardo Santos‐Ramos

et al.

Research in Social and Administrative Pharmacy, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Language: Английский

Citations

0